Bundamedik Tbk PT (JK:BMHS) — Market Cap & Net Worth
Market Cap & Net Worth: Bundamedik Tbk PT (BMHS)
Bundamedik Tbk PT (JK:BMHS) has a market capitalization of $93.26 Million (Rp1.59 Trillion) as of May 2, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #19446 globally and #357 in its home market, demonstrating a -0.54% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bundamedik Tbk PT's stock price Rp185.00 by its total outstanding shares 8603416176 (8.60 Billion). Analyse Bundamedik Tbk PT cash conversion from operations to see how efficiently the company converts income to cash.
Bundamedik Tbk PT Market Cap History: 2021 to 2026
Bundamedik Tbk PT's market capitalization history from 2021 to 2026. Data shows change from $414.12 Million to $93.26 Million (-15.63% CAGR).
Index Memberships
Bundamedik Tbk PT is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Jakarta Stock Exchange Composite Index
JKSE
|
$540.85 Billion | 0.02% | #349 of 864 |
Weight: Bundamedik Tbk PT's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Bundamedik Tbk PT Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bundamedik Tbk PT's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Bundamedik Tbk PT's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
Bundamedik Tbk PT's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $414.12 Million | $1.71 Trillion | $315.36 Billion | 0.00x | 0.00x |
| 2022 | $206.44 Million | $1.66 Trillion | $128.93 Billion | 0.00x | 0.00x |
| 2023 | $164.04 Million | $1.49 Trillion | $7.46 Billion | 0.00x | 0.02x |
| 2024 | $124.01 Million | $1.55 Trillion | $11.94 Billion | 0.00x | 0.01x |
Competitor Companies of BMHS by Market Capitalization
Companies near Bundamedik Tbk PT in the global market cap rankings as of May 2, 2026.
Key companies related to Bundamedik Tbk PT by market ranking:
- HCA Holdings Inc (NYSE:HCA): Ranked #256 globally with a market cap of $96.85 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #962 globally with a market cap of $27.16 Billion USD ( €23.23 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #972 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1292 globally with a market cap of $19.57 Billion USD ( RM77.93 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #256 | HCA Holdings Inc | NYSE:HCA | $96.85 Billion | $433.09 |
| #962 | Fresenius SE & Co. KGaA | XETRA:FRE | $27.16 Billion | €41.25 |
| #972 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1292 | IHH Healthcare Bhd | KLSE:5225 | $19.57 Billion | RM8.82 |
Bundamedik Tbk PT Historical Marketcap From 2021 to 2026
Between 2021 and today, Bundamedik Tbk PT's market cap moved from $414.12 Million to $ 93.26 Million, with a yearly change of -15.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp93.26 Million | -2.63% |
| 2025 | Rp95.78 Million | -22.76% |
| 2024 | Rp124.01 Million | -24.40% |
| 2023 | Rp164.04 Million | -20.54% |
| 2022 | Rp206.44 Million | -50.15% |
| 2021 | Rp414.12 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Bundamedik Tbk PT was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $93.26 Million USD |
| MoneyControl | $93.26 Million USD |
| MarketWatch | $93.26 Million USD |
| marketcap.company | $93.26 Million USD |
| Reuters | $93.26 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bundamedik Tbk PT
PT Bundamedik Tbk provides health care services in Indonesia. It also engages private hospital and healthcare support service activities; provision of ambulance services; private health education; consultant for reproductive technology services management; management consultant of physiotherapy service; and hotel, medical tourism, and dental clinic services management consulting businesses. It al… Read more